Results 21 to 30 of about 19,009 (196)
Thrombocytopenia between decitabine monotherapy vs decitabine combination.
Thrombocytopenia between decitabine monotherapy vs decitabine combination.
Romina Brignardello-Petersen (814592) +7 more
core +1 more source
Febrile neutropenia events between decitabine monotherapy vs decitabine combination.
Febrile neutropenia events between decitabine monotherapy vs decitabine combination.
Romina Brignardello-Petersen (814592) +7 more
core +1 more source
Decitabine is an approved hypomethylating agent used for treating hematological malignancies. Although decitabine targets altered cells, epidrugs can trigger immunomodulatory effects, reinforcing the hypothesis of immunoregulation in treated patients. We
Fabiana Albani Zambuzi +5 more
doaj +1 more source
Pneumonia events between decitabine monotherapy vs decitabine combination.
Pneumonia events between decitabine monotherapy vs decitabine combination.
Romina Brignardello-Petersen (814592) +7 more
core +1 more source
Anemia events between decitabine monotherapy vs decitabine combination.
Anemia events between decitabine monotherapy vs decitabine combination.
Romina Brignardello-Petersen (814592) +7 more
core +1 more source
Objective Anthracyclines and cytarabine have comprised standard induction therapy for acute myeloid leukemia (AML) for decades. Low overall survival of AML is due to non-remission or relapse after remission.
Zhibo Guo +12 more
doaj +1 more source
Neutropenia events between decitabine monotherapy vs decitabine combination.
Neutropenia events between decitabine monotherapy vs decitabine combination.
Romina Brignardello-Petersen (814592) +7 more
core +1 more source
Downregulation of tumor suppression genes by DNA hypermethylation has been proposed as a potential cause of neuroendocrine neoplasm (NEN) formation. In this report, we present a patient simultaneously diagnosed with acute myeloid leukemia (AML) and a ...
Syed Ehsanullah, Nikolaos A Trikalinos
doaj +1 more source
Therapeutic effect of folic acid combined with decitabine on diabetic mice [PDF]
AIM: To evaluate the therapeutic effect of folic acid combined with decitabine on diabetic mice. METHODS: The diabetic model of db/db mice were randomly divided into model group, folic acid group, decitabine group, folic acid combined with decitabine ...
Gang Du +5 more
doaj +1 more source
MLL‐rearranged acute lymphoblastic leukemia (ALL) represents a highly aggressive ALL subtype, characterized by aberrant DNA methylation patterns. DNA methyltransferase inhibitors, such as decitabine have previously been demonstrated to be effective in ...
Pauline Schneider +9 more
doaj +1 more source

